0.2-0.5 Tesla MRi for the detection of arthritis and musculoskeletal disease (Structured abstract)      
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children (Structured abstract)      
10th Symposium Health Technology Assessment, Nothing without evidence? 18th-19th March 2010, Cologne (Structured abstract)      
(111)In-capromab pendetide for staging prostate cancer in men at high risk of metastasis (Structured abstract)      
11th Symposium Health Technology Assessment, theoretical practice - practical theory? 17th to 18th March 2011, Cologne (Structured abstract)      
13-cis-retinoic acid (isotretinoin) for the treatment of glioblastoma multiforme (Structured abstract)      
131-iodine tositumomab for non-Hodgkin's lymphoma - horizon scanning review (Structured abstract)      
The 13C-urea breath test for detection of helicobacter pylori: potential applications in Quebec (Structured abstract)      
1,4-Dioxane - re-evaluation of the carcinogenicity and genotoxicity (Structured abstract)      
18-f-sodium fluoride (18-f-naf) bone positron emission tomography, positron emission tomography/computed tomography (Structured abstract)      
18-FDG positron emission tomography for melanoma (Structured abstract)      
18-FDG positron emission tomography for non-small cell lung cancer: cost-effectiveness reports (Structured abstract)      
18-FDG positron emission tomography for non-small cell lung cancer (Structured abstract)      
18-FDG positron emission tomography in oncology: HTA reports by international HTA agencies (Structured abstract)      
1996 reports of the Health Council of the Netherlands (executive summaries) (Structured abstract)      
The 1998 reports of the Health Council of the Netherlands (Executive summaries) (Structured abstract)      
1st Expert Panel on viper venomous bite in Spain (Structured abstract)      
1st Symposium Health Technology Assessment - Current state and perspectives in German speaking countries, 2000, May 3 - 4, Cologne (Structured abstract)      
23g and 25g vitrectomy for eye conditions (Structured abstract)      New 
24-hour ambulatory blood pressure monitoring (Structured abstract)      
2,6-Xylidine - re-evaluation of the carcinogenicity and genotoxicity (Structured abstract)      
3 Tesla Magnetic Resonance Imaging (Structured abstract)      
3.0 Tesla (3T) Magnetic Resonance Imaging (MRI) for multiple sclerosis (Structured abstract)      
3.0 Tesla (3T) Magnetic Resonance Imaging (MRI) for Prostate Cancer (Structured abstract)      
3F8 monoclonal antibody therapy for the treatment of pediatric neuroblastoma (Structured abstract)      
The 3Mg Trial: Randomised controlled trial of intravenous or nebulised magnesium sulphate or standard therapy for acute severe asthma (Structured abstract)      
4,4'-Methylenedianiline - Health-based calculated occupational cancer risk values (Structured abstract)      
4D Ultrasound (Structured abstract)      
4th Symposium Health Technology Assessment - Evaluation of medical procedures, 2003, November 13 - 14, Krefeld (Structured abstract)      
5-aminolaevulinic acid (Ameluz®) (Structured abstract)      
5-fluorouracil (5-FU) as adjuvant chemotherapy in Duke's stage C colorectal cancer (Structured abstract)      
5-HT1 agonists for migraine - update (Structured abstract)      
5-HT3 antagonist update (2004) (Structured abstract)      
5-HT3 antagonists update (Structured abstract)      
5-Nitroacenaphthene (Structured abstract)      
532 nm KTP laser for vocal fold surgery (Structured abstract)      
64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease (Structured abstract)      
64-slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease (Structured abstract)      
8th Symposium Health Technology Assessment - Decision-making in medicine, 2007, October 18 - 19, Cologne (Structured abstract)      
900,000 days in hospital: The annual impact of smoking, alcohol, diet and physical activity on hospital use in Ontario (Structured abstract)      
90Y-muHMFG1 for ovarian cancer - horizon scanning review (Structured abstract)      
90Yttrium radioembolisation for hepatocellular carcinoma and colorectal liver metastases (Structured abstract)      
9th Symposium Health Technology Assessment - Patients in no man's land, 2008, October 17 - 18, Cologne (Structured abstract)